CompletedNCT00206778
Lamotrigine compared with sodium valproate for mixed mania in bipolarity
About this title
Read the official source — NCT00206778Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJuly 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 36
- Sponsor
- Beth Israel Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00206778
- Official title
Show the full official title
A Randomized Open-Label 6 Month Acute and Maintenance Trial of Lamotrigine vs. Standard of Care Sodium Valproate Monotherapy for Treatment of Mixed Mania.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Beth Israel Medical Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including lamotrigine and Sodium Valproate.
Who was this study for?
Listed age limits: 18 years to 65 years.
